期刊文献+

妊娠合并非霍奇金淋巴瘤1例并文献复习 被引量:1

Non-Hodgkin' s lymphoma-complicated pregnancy: a case report and literature review
暂未订购
导出
摘要 目的探讨妊娠期恶性淋巴瘤的化疗与胎儿宫内生长、分娩的相互影响及孕期处理。方法回顾性分析本院1例非霍奇金淋巴瘤(NHL)患者治疗及因特殊原因不能终止妊娠而成功分娩的经过,并以“妊娠”和“恶性淋巴瘤”为主题词于“中国知网”进行文献检索,对自1992年11月-2010年9月国内报道的15例“妊娠合并恶性淋巴瘤”相关病例报道进行研究,分析妊娠期恶性淋巴瘤患者的化疗选择及对胎儿生长、母体结局的影响。结果妊娠期合并恶性淋巴瘤不易早期发现,进展快、侵袭性强、肿瘤负荷大,危及生命;对妊娠及母体的影响,包括流产、早产、胎死宫内及感染出血等。本例患者合并上腔静脉压迫综合征,无法早期结束妊娠,靶向治疗联合化疗后,病变控制缓解,获得成功分娩。结论妊娠合并恶性淋巴瘤经过合理选择治疗,继续妊娠至胎儿成熟分娩,分娩后补充完成化、放疗,可获得良好的妊娠结局及母体生存。治疗对于婴儿的近远期影响在随访观察中。 Objective To examine the impact of chemotherapy for malignant lymphoma during pregnancy and the intrauterine growth of the fetus and pregnancy outcomes. Methods The medical record of a pregnant woman who had non-Hodgkin' s lymphoma with a successful delivery in our hospital was reviewed. A search to the CNKI literature database using the keywords of "pregnancy" and "malignant lymphoma". Reports of 15 cases of malignant lymphoma-complicated pregnancies were retrieved during November 1992 to September 2010 in China. These reports were reviewed regarding the effects of pregnancy complicated by malignant lymphoma treated with chemotherapy on fetal growth and pregnancy out- comes. Results Malignant lymphoma during pregnancy was difficult to diagnose in early stage, and therefore the malig- nancy advanced rapidly, threatening the lives of the fetus and the mother. Major effects chemotherapy include miscarriage, stillbirth, premature birth, infection, and bleeding. We did not choose early termination in this patient due to evident supe- rior vena cava syndrome, and managed to delivery at 33 weeks of gestation with the relief of the disease with targeted thera- py combined with chemotherapy. Conclusion Malignant lymphoma in pregnancy is life threatening. Good pregnancy outcomes in pregnancies complicated with non-Hodgkin's lymphoma could be achieved by radiotherapy and chemotherapy personalized to the patient.
出处 《中国生育健康杂志》 2012年第2期100-104,共5页 Chinese Journal of Reproductive Health
关键词 妊娠 非霍奇金淋巴瘤 化学疗法 Pregnancy Non-Hodgkin' s lymphoma Chemotherapy
  • 相关文献

参考文献6

  • 1Lishner M,Zemlickis D,Sutcliffe SB,et al.Non-Hodgkin's lymphomas and pregnancy.Gynecol Oncol,1994,14:411-413.
  • 2Spitzer M,Citron M,Iiardi CF,et al.Non-Hodgkin's lymphomas during pregnancy.Gynecol Oncol,1991,43:309-312.
  • 3付景丽,宋薇薇.妊娠合并妇科恶性肿瘤继续妊娠的孕期监护[J].中国实用妇科与产科杂志,2007,23(10):751-753. 被引量:4
  • 4徐俊.妊娠合并恶性肿瘤22例临床分析[J].医药论坛杂志,2010,31(17):41-43. 被引量:8
  • 5Germann N,Haie C,Morice P,et al.Management and clinical outcome of pregnant patients with invasive cervical cancer.Ann Oncol,2005,16:397-402.
  • 6Jameel A,Jamil SN.Safety of cytotoxic chemotherapy during pregnancy.J Pak Med Assoc,2007,57:449-452.

二级参考文献22

  • 1叶大风,石一复.妊娠期原发性卵巢癌17例临床分析[J].实用妇产科杂志,1993,9(6):317-318. 被引量:2
  • 2马万增.卵巢癌的术后监测[J].基层医学论坛,2005,9(2):148-148. 被引量:1
  • 3邹洪香,孙明忠.血清CA125、CA19-9和SF联合测定在卵巢恶性肿瘤诊断中的运用[J].中国误诊学杂志,2005,5(3):459-459. 被引量:3
  • 4顾平(综述),盛世乐(审校),黄钢(审校).肿瘤标志物在卵巢癌中的应用[J].国际肿瘤学杂志,2007,34(3):226-228. 被引量:6
  • 5Oduncu FS, Mig RH. Cancer in pregnancy: maternal - fetal conflict[ J ]. Journal of Cancer Research & Clinical Oncology,2003,129(3 ) : 133-146.
  • 6Pavlidis NA. Coexistence of pregnancy and malignancy [ J ]. Oncologist, 2002,7 ( 4 ): 279 -287.
  • 7Rizack T, Mega A, Legare R, et al. Management of hematological malignancies during pregnancy. American journal of hematology, 2009,4 ( 12 ) : 830-841.
  • 8Gemann N, Haie C, Morice P, et al. Management and clinical outcome of pregnant patients with invasive cervical cancer [ J ]. Ann Oncol, 2005 ( 3 ), 16 : 397-402.
  • 9Jameel A, Jamil SN. Safety of cytotoxic chemotherapy during pregnancy[ J ]. The Journal of the Pakistan Medical Association, 2007,57 ( 9 ) : 449-52.
  • 10Hubalek M, Smekal - Schindelwig C, Zeimet AG, et al. Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma [ J ]. Archives of gynecology and obstetrics, 2007,276 (2) : 179-83.

共引文献10

同被引文献10

  • 1Messori A,Vaiani M,Trippoli S,et al.Survival in patients with intermediate or high grade non-Hodgkin's lymphoma metaanalysis of randomized studies comparing third generation regimen with CHOP[J].Br J Cancer,2001,84:303-307.
  • 2Buzzoni R,Coueom M,Neui P,et al.Results of a slvage regimen in refractory or relapsed non-Hodgkin's lymphoma[J].Leuk Lymphoma,1994,14(1):121-128.
  • 3Philip T,Guglielmi C,Hagenbeek A,et al.Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma[J].N Engl J Med,1995,333(13):1540-1545.
  • 4Cheson BD,Leonard JP.Monoclonal antibody therapy for B-cell Non-Hodgkin's lymphoma[J].N Engl J Med,2008,359 (6):613-626.
  • 5Philip T,Guglielmi C,Hagenbeek A,et al.Autologous bone marrow transplantation as compared,with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma[J].N Engl J Med,1995,333(13):1540-1545.
  • 6Bergman AM,Pinedo HM,Talianidis I,et al.Increased sensitivity to gemcitabine of P-gly-coprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines[J].Br J Cancer,2003,88(12):1963-1970.
  • 7Fossa A,Santoro A,Hiddemann W,et al.Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma[J].J Clin Oncol,1997,17(12):3786-3792.
  • 8Crump M,Baelz T,Couban S.Gencitabine,dexamethasone,and cisplatin in patients with recurrence or refractory aggressive histology B-cell non-Hodgkin's lymphoma[J].Cancer,2004,101:1835-1842.
  • 9范云,黄志煜,罗吕宏,余海峰.GDP方案治疗24例复发、耐药侵袭性非霍奇金淋巴瘤临床分析[J].癌症,2008,27(11):1222-1225. 被引量:13
  • 10梁进,申政磊,毕清.吉西他滨联合顺铂和地塞米松治疗复发或难治性非霍奇金淋巴瘤30例疗效观察[J].海南医学,2009,20(S2):155-157. 被引量:6

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部